Induction of Apoptosis and G2/M Cell Cycle Arrest by Cordycepin in Human Prostate Carcinoma LNCap Cells
![]() |
Lee, Hye Hyeon
(Department of Biotechnology, College of Natural Resources and Life Science, Dong-A University)
Hwang, Won Deok (Department of Internal Medicine, Dongeui University College of Oriental Medicine) Jeong, Jin-Woo (Center for Core Research Facilities, Daegu-Gyeongbuk Institute of Science & Technology) Park, Cheol (Department of Molecular Biology, College of Natural Sciences, Dongeui University) Han, Min Ho (Department of Biochemistry, Dongeui University College of Oriental Medicine) Hong, Su Hyun (Department of Biochemistry, Dongeui University College of Oriental Medicine) Jeong, Yong Kee (Department of Biotechnology, College of Natural Resources and Life Science, Dong-A University) Choi, Yung Hyun (Department of Biochemistry, Dongeui University College of Oriental Medicine) |
1 | Cuddihy, A. and O'Connell, M. 2003. Cell-cycle responses to DNA damage in G2. Int Rev Cytol 222, 99-140. DOI |
2 | Boutros, R., Dozier, C. and Ducommun, B. 2006. The when and wheres of CDC25 phosphatases. Curr Opin Cell Biol 18, 185-191. DOI ScienceOn |
3 | Carroll, A. G., Voeller, H. J., Sugars, L. and Gelmann, E. P. 1993. p53 oncogene mutations in three human prostate cancer cell lines. Prostate 23, 123-134. DOI ScienceOn |
4 | Chen, L. S., Stellrecht, C. M. and Gandhi, V. 2008. RNA-directed agent, cordycepin, induces cell death in multiple myeloma cells. Br J Haematol 140, 682-691. DOI ScienceOn |
5 | Choi, S., Lim, M. H., Kim, K. M., Jeon, B. H., Song, W. O. and Kim, T. W. 2011. Cordycepin-induced apoptosis and autophagy in breast cancer cells are independent of the estrogen receptor. Toxicol Appl Pharmacol 257, 165-173. DOI |
6 | Jeong, J. W., Jin, C. Y., Park, C., Hong, S. H., Kim, G. Y., Jeong, Y. K., Lee, J. D., Yoo, Y. H. and Choi, Y. H. 2011. Induction of apoptosis by cordycepin via reactive oxygen species generation in human leukemia cells. Toxicol In Vitro 25, 817-824. DOI ScienceOn |
7 | Han, S. J. and Conti, M. 2006. New pathways from PKA to the Cdc2/cyclin B complex in oocytes: Wee1B as a potential PKA substrate. Cell Cycle 5, 227-231. DOI ScienceOn |
8 | Jeong, J. W., Jin, C. Y., Kim, G. Y., Lee, J. D., Park, C., Kim, G. D., Kim, W. J., Jung, W. K., Seo, S. K., Choi, I. W. and Choi, Y. H. 2010. Anti-inflammatory effects of cordycepin via suppression of inflammatory mediators in BV2 microglial cells. Int Immunopharmacol 10, 1580-1586. DOI ScienceOn |
9 | Jeong, J. W., Jin, C. Y., Park, C., Han, M. H., Kim, G. Y., Moon, S. K., Kim, C. G., Jeong, Y. K., Kim, W. J., Lee, J. D. and Choi, Y. H. 2012. Inhibition of migration and invasion of LNCaP human prostate carcinoma cells by cordycepin through inactivation of Akt. Int J Oncol 40, 1697-1704. |
10 | Jeong, M. H., Seo, M. J., Park, J. U., Kang, B. W., Kim, K. S., Lee, J. Y., Kim, G. Y., Kim, J. I., Choi, Y. H., Kim, K. H. and Jeong, Y. K. 2012. Effect of cordycepin purified from Cordyceps militaris on Th1 and Th2 cytokines in mouse splenocytes. J Microbiol Biotechnol 22, 1161-1164. DOI |
11 | Jung, S. M., Park, S. S., Kim, W. J. and Moon, S. K. 2012. Ras/ERK1 pathway regulation of p27KIP1-mediated G1-phase cell-cycle arrest in cordycepin-induced inhibition of the proliferation of vascular smooth muscle cells. Eur J Pharmacol 681, 15-22. DOI |
12 | Kim, H. G., Shrestha, B., Lim, S. Y., Yoon, D. H., Chang, W. C., Shin, D. J., Han, S. K., Park, S. M., Park, J. H., Park, H. I., Sung, J. M., Jang, Y., Chung, N., Hwang, K. C. and Kim, T. W. 2006. Cordycepin inhibits lipopolysaccharide-induced inflammation by the suppression of NF-kappaB through Akt and p38 inhibition in RAW 264.7 macrophage cells. Eur J Pharmacol 545, 192-199. DOI ScienceOn |
13 | Lee, H. H., Park, C., Jeong, J. W., Kim, M. J., Seo, M. J., Kang, B. W., Park, J. U., Kim, G. Y., Choi, B. T., Choi, Y. H. and Jeong, Y. K. 2013. Apoptosis induction of human prostate carcinoma cells by cordycepin through reactive oxygen speciesmediated mitochondrial death pathway. Int J Oncol 42, 1036-1044. |
14 | Lee, S. J., Kim, S. K., Choi, W. S., Kim, W. J. and Moon, S. K. 2009. Cordycepin causes p21WAF1-mediated G2/M cell-cycle arrest by regulating c-Jun N-terminal kinase activation in human bladder cancer cells. Arch Biochem Biophys 490, 103-109. DOI ScienceOn |
15 | Kondrashov, A., Meijer, H. A., Barthet-Barateig, A., Parker, H. N., Khurshid, A., Tessier, S., Sicard, M., Knox, A. J., Pang, L. and De Moor, C. H. 2012. Inhibition of polyadenylation reduces inflammatory gene induction. RNA 18, 2236-2250. DOI |
16 | Lee, S. J., Moon, G. S., Jung, K. H., Kim, W. J. and Moon, S. K. 2010. c-Jun N-terminal kinase 1 is required for cordycepin-mediated induction of G2/M cell-cycle arrest via p21WAF1 expression in human colon cancer cells. Food Chem Toxicol 48, 277-283. DOI ScienceOn |
17 | Lee, H. H., Jeong, J. W., Lee, J. H., Kim, G. Y., Cheong, J., Jeong, Y. K., Yoo, Y. H. and Choi, Y. H. 2013. Cordycepin increases sensitivity of Hep3B human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by inactivating the JNK signaling pathway. Oncol Rep doi: 10.3892/or.2013. 2589. DOI |
18 | Müller, W. E., Seibert, G., Beyer, R., Breter, H. J., Maidhof, A. and Zahn, R. K. 1977. Effect of cordycepin on nucleic acid metabolism in L5178Y cells and on nucleic acid-synthesizing enzyme systems. Cancer Res 37, 3824-3833. |
19 | Nakamura, K., Yoshikawa, N., Yamaguchi, Y., Kagota, S., Shinozuka, K. and Kunitomo, M. 2006. Antitumor effect of cordycepin (3'-deoxyadenosine) on mouse melanoma and lung carcinoma cells involves adenosine A3 receptor stimulation. Anticancer Res 26, 43-47. |
20 | Niida, H. and Nakanishi, M. 2006. DNA damage checkpoints in mammals. Mutagenesis 21, 3-9. |
21 | Shin, S., Lee, S., Kwon, J., Moon, S., Lee, S., Lee, C. K., Cho, K., Ha, N. J. and Kim, K. 2009. Cordycepin suppresses expression of diabetes regulating genes by inhibition of lipopolysaccharide-induced inflammation in macrophages. Immune Netw 9, 98-105. DOI |
22 |
Ren, Z., Cui, J., Huo, Z., Xue, J., Cui, H., Luo, B., Jiang, L. and Yang, R. 2012. Cordycepin suppresses TNF- |
23 | Paterson, R. R. 2008. Cordyceps: a traditional Chinese medicine and another fungal therapeutic biofactory?. Phytochemistry 69, 1469-1495. DOI ScienceOn |
24 | Ramesh, T., Yoo, S. K., Kim, S. W., Hwang, S. Y., Sohn, S. H., Kim, I. W. and Kim, S. K. 2012. Cordycepin (3'-deoxyadenosine) attenuates age-related oxidative stress and ameliorates antioxidant capacity in rats. Exp Gerontol 47, 979-987. DOI ScienceOn |
25 | Siev, M., Weinberg, R. and Penman, S. 1969. The selective interruption of nucleolar RNA synthesis in HeLa cells by cordycepin. J Cell Biol 41, 510-520. DOI |
26 | Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S. and Dixit, V. M. 1995. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81, 801-809. DOI ScienceOn |
27 | Raleigh, J. M. and O’Connell, M. J. 2000. The G(2) DNA damage checkpoint targets both Wee1 and Cdc25. J Cell Sci 113, 1727-1736. |
28 | Xiao, L., Ge, Y., Sun, L., Xu, X., Xie, P., Zhan, M., Wang, M., Dong, Z., Li, J., Duan, S., Liu, F. and Xiao, P. 2012. Cordycepin inhibits albumin-induced epithelial-mesenchymal transition of renal tubular epithelial cells by reducing reactive oxygen species production. Free Radic Res 46, 174-183. DOI |
29 | Yue, K., Ye, M., Zhou, Z., Sun, W. and Lin, X. 2013. The genus Cordyceps: a chemical and pharmacological review. J Pharm Pharmacol 65, 474-493. DOI ScienceOn |
30 | Zhou, X., Luo, L., Dressel, W., Shadier, G., Krumbiegel, D., Schmidtke, P., Zepp, F. and Meyer, C. U. 2008. Cordycepin is an immunoregulatory active ingredient of Cordyceps sinensis. Am J Chin Med 36, 967-980. DOI |
![]() |